Cybrdi, Inc. Receivables Turnover Ratio (CYDI), from the third quarter 2014 to the third quarter 2013 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cybrdi, Inc.  (CYDI)
 

Cybrdi Accounts Receivables Turnover Ratio from the third quarter 2014 to the third quarter 2013

Quarterly Results, Trends, Rankings, Statistics


Cybrdi, Inc.'s ability to collect accounts receivable sequentially worsen to 8.79, indicating more challenging environment then in the second quarter 2014, but still, it is a far cry from any concerns. Cybrdi's Accounts Receivable average collection period in the Sep 30 2014 quarter, has increased to 42 days, from 26 days, in the Jun 30 2014 quarter.

If we take a look into Healthcare sector 325 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2014 from 1434 to 3514.

What is Receivable Turnover Ratio?
What is Cybrdi, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CYDI Receivables Turnover Ratio (Sep 30 2014)
III. Quarter		 (Jun 30 2014)
II. Quarter		 (Mar 31 2014)
I. Quarter		 (Dec 31 2013)
IV. Quarter		 (Sep 30 2013)
III. Quarter
Y / Y Receivable Change 1002.66 % 418.54 % 215.31 % 1200 % -91.77 %
Y / Y Revenue Change -15.81 % -38.35 % -1.57 % -49.4 % 3.03 %
Receivable Turnover Ratio (TTM) 8.79 14.27 28.49 49.95 72.08
CYDI's Total Ranking # 3514 # 1434 # 1434 # 0 # 1434
Accounts Receivable average collection period days 42 26 13 7 5
Seq. Receivable Change 10.57 % 60.64 % 683.82 % -20.8 % -48 %
Seq. Revenue Change 30.88 % -42.52 % -1.79 % 13.96 % -4.17 %


Receivable Turnover Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 21
Healthcare Sector # 326
Overall Market # 3514

Receivable Turnover Ratio Statistics
High Average Low
0.08 0.06 0.05
(Dec 31 2012)  





CYDI Company Profile • Back to CYDI Efficiency Comparisons • Compare CYDI Receivables Turnover Ratio to its Competitors

Financial Statements
Cybrdi's Accounts Receivable $ 0 Millions Visit CYDI's Balance sheet
Cybrdi's Sales TTM $ 0 Millions Visit CYDI's Income Statement
Sources of CYDI's Revenues Visit CYDI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CYDI's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CYDI's Growth Rates CYDI's Roa CYDI's Inventory Turnover Ratio CYDI's Dividend Comparisons
CYDI's Profitability Ratios CYDI's Roi CYDI's Asset Turnover Ratio CYDI's Dividend Growth
CYDI's Valuation Ratios CYDI's Roe CYDI's Financial Strength Ratios CYDI's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2014, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2014 Receivable at quarter ending Sep 30 2014
Integrated Biopharma Inc  15.20 $ 33.074  Millions$ 2.176  Millions
Lifeloc Technologies Inc   14.80 $ 8.939  Millions$ 0.604  Millions
Cyclo Therapeutics Inc   14.58 $ 1.356  Millions$ 0.093  Millions
Adma Biologics Inc   14.49 $ 6.701  Millions$ 0.463  Millions
Magellan Health inc   14.48 $ 3,785.869  Millions$ 261.376  Millions
Aveo Pharmaceuticals Inc   14.29 $ 18.331  Millions$ 1.283  Millions
Ligand Pharmaceuticals Incorporated  14.21 $ 56.276  Millions$ 3.960  Millions
Asensus Surgical Inc   14.11 $ 1.319  Millions$ 0.094  Millions
Davita Inc   13.55 $ 20,250.401  Millions$ 1,494.654  Millions
Acorda Therapeutics Inc   13.45 $ 376.201  Millions$ 27.967  Millions
Tenet Healthcare Corp  13.40 $ 28,106.000  Millions$ 2,097.000  Millions
Beam Therapeutics Inc   13.22 $ 1,334.647  Millions$ 100.967  Millions
Chemed Corporation  13.19 $ 1,425.475  Millions$ 108.104  Millions
Dyax Corp  12.66 $ 72.554  Millions$ 5.730  Millions
Insite Vision Inc  12.61 $ 8.930  Millions$ 0.708  Millions
Musclepharm Corporation  12.58 $ 182.210  Millions$ 14.485  Millions
Rockwell Medical inc   12.57 $ 53.705  Millions$ 4.272  Millions
Imunon Inc   12.36 $ 0.500  Millions$ 0.040  Millions
Tandem Diabetes Care Inc   12.16 $ 42.079  Millions$ 3.462  Millions
Hca Healthcare Inc   12.12 $ 65,737.000  Millions$ 5,423.250  Millions
Strata Skin Sciences Inc  12.05 $ 0.680  Millions$ 0.056  Millions
Alaunos Therapeutics Inc   11.97 $ 1.233  Millions$ 0.103  Millions
Immucell Corporation  11.86 $ 6.951  Millions$ 0.586  Millions
Apyx Medical Corp  11.86 $ 26.343  Millions$ 2.222  Millions
Noho, Inc.  11.83 $ 1.177  Millions$ 0.100  Millions
Merrimack Pharmaceuticals Inc  11.28 $ 76.674  Millions$ 6.796  Millions
First Choice Healthcare Solutions Inc   11.27 $ 20.262  Millions$ 1.797  Millions
Aspira Women s Health inc   11.19 $ 2.548  Millions$ 0.228  Millions
Procyon Corporation  11.18 $ 2.726  Millions$ 0.244  Millions
Surmodics Inc   11.13 $ 57.439  Millions$ 5.162  Millions

Date modified: 2026-09-08T15:07:44+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.